[11C]ER-176
Tier C — Watch / trade[11C]ER-176
Targets：TSPO
Indications (approved)：Alzheimer's disease, Dementia
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| [11C]ER-176-001 | 2894-45-3 | (2-aminophenyl)(2-chlorophenyl)methanone |
| [11C]ER-176-002 | 1373887-64-9 | 4-(2-chlorophenyl)quinazoline-2-carboxylic acid |
| [11C]ER-176-003 | 13250-12-9 | (R)-butan-2-amine |
| [11C]ER-176-004 | 1373887-55-8 | (R)-N-(sec-butyl)-4-(2-chlorophenyl)quinazoline-2-carboxamide |
| [11C]ER-176 | 1623028-18-1 | 2-Quinazolinecarboxamide, 4-(2-chlorophenyl)-N-(methyl-11C)-N-[(1R)-1-methylpropyl]- |
Frequently asked questions
What are the approved indications of [11C]ER-176?
Approved indications include: Alzheimer's disease, Dementia.
When does the [11C]ER-176 patent expire?
No public expiry year is available for [11C]ER-176 yet; this page updates once verified.
How many synthesis routes are recorded for [11C]ER-176?
1 synthesis routes are recorded; the shortest is 3 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy [11C]ER-176 intermediates?
All intermediates in [11C]ER-176 routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for [11C]ER-176 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-08